 |
Previous Article | Next Article 
The Journal of Neuroscience, June 15, 2002, 22(12):4885-4896
Perineuronal Oligodendrocytes Protect against Neuronal Apoptosis
through the Production of Lipocalin-Type Prostaglandin D Synthase in a
Genetic Demyelinating Model
Masako
Taniike1, *,
Ikuko
Mohri1, *,
Naomi
Eguchi2, 3, *,
Carsten T.
Beuckmann2,
Kinuko
Suzuki4, and
Yoshihiro
Urade2, 3
1 Department of Developmental Medicine (Pediatrics),
D-5 Osaka University Graduate School of Medicine, Osaka 565-0871, Japan, 2 Department of Molecular Behavioral Biology and
3 Core Research for Evolutional Science and Technology,
Japan Science and Technology Corporation, Osaka Bioscience Institute,
Osaka 565-0874, Japan, and 4 Department of Pathology and
Laboratory Medicine, and Neuroscience Center, School of Medicine,
University of North Carolina at Chapel Hill, Chapel Hill, North
Carolina 27599-7525
The genetic demyelinating mouse "twitcher" is a model of the
human globoid cell leukodystrophy, caused by galactosylceramidase (GALC) deficiency. Demyelination in the twitcher brain is secondary to
apoptotic death of oligodendrocytes (OLs). Lipocalin-type prostaglandin (PG) D synthase (L-PGDS), a protein expressed in mature OLs, was progressively upregulated in twitcher OLs; whereas expression of
OL-associated proteins such as carbonic anhydrase II, myelin basic
protein, and myelin-associated glycoprotein was downregulated during
demyelination in twitcher brains. The upregulation of L-PGDS was more
remarkable in perineuronal OLs than in interfascicular OLs. A larger
number of L-PGDS-positive OLs was found in selected fiber tracts of
twitcher brains where fewer apoptotic cells were detected. The
distribution of L-PGDS-positive OLs was inversely related to the
severity of demyelination, as assessed by accumulation of scavenger
macrophages. Mice doubly deficient for L-PGDS and GALC disclosed a
large number of apoptotic neurons, which were never seen in twitcher
brains, in addition to an increased number of apoptotic OLs. A linear
positive correlation was observed between the population of
L-PGDS-positive OLs in the twitcher brain and the ratio of apoptotic
nuclei in the double mutant versus those in the twitcher, suggesting a
dose-dependent effect of L-PGDS against apoptosis. These lines of
evidence suggest that L-PGDS is an anti-apoptotic molecule protecting
neurons and OLs from apoptosis in the twitcher mouse. This is a novel
example of OL-neuronal interaction.
Key words:
prostaglandin D2; lipocalin-type
prostaglandin D synthase; twitcher; oligodendrocyte; demyelination; galactosylceramidase; apoptosis
*
M.T., I.M., and N.E. contributed equally to this work.
Copyright © 2002 Society for Neuroscience 0270-6474/02/22124885-12$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
M. A. Lovell, B. C. Lynn, S. Xiong, J. F. Quinn, J. Kaye, and W. R. Markesbery
An aberrant protein complex in CSF as a biomarker of Alzheimer disease
Neurology,
June 3, 2008;
70(23):
2212 - 2218.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Li, T. M. Malpica-Llanos, R. Gundry, R. J. Cotter, N. Sacktor, J. McArthur, and A. Nath
Nitrosative stress with HIV dementia causes decreased L-prostaglandin D synthase activity
Neurology,
May 6, 2008;
70(19_Part_2):
1753 - 1762.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Taniguchi, I. Mohri, H. Okabe-Arahori, K. Aritake, K. Wada, T. Kanekiyo, S. Narumiya, M. Nakayama, K. Ozono, Y. Urade, et al.
Prostaglandin D2 Protects Neonatal Mouse Brain from Hypoxic Ischemic Injury
J. Neurosci.,
April 18, 2007;
27(16):
4303 - 4312.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. E. Killer, G. P. Jaggi, J. Flammer, N. R. Miller, A. R. Huber, and A. Mironov
Cerebrospinal fluid dynamics between the intracranial and the subarachnoid space of the optic nerve. Is it always bidirectional?
Brain,
February 1, 2007;
130(2):
514 - 520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Aritake, Y. Kado, T. Inoue, M. Miyano, and Y. Urade
Structural and Functional Characterization of HQL-79, an Orally Selective Inhibitor of Human Hematopoietic Prostaglandin D Synthase
J. Biol. Chem.,
June 2, 2006;
281(22):
15277 - 15286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Mohri, M. Taniike, H. Taniguchi, T. Kanekiyo, K. Aritake, T. Inui, N. Fukumoto, N. Eguchi, A. Kushi, H. Sasai, et al.
Prostaglandin D2-mediated microglia/astrocyte interaction enhances astrogliosis and demyelination in twitcher.
J. Neurosci.,
April 19, 2006;
26(16):
4383 - 4393.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. E. Killer, G. P. Jaggi, J. Flammer, N. R. Miller, and A. R. Huber
The optic nerve: a new window into cerebrospinal fluid composition?
Brain,
April 1, 2006;
129(4):
1027 - 1030.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Fujimori, K. Kadoyama, and Y. Urade
Protein Kinase C Activates Human Lipocalin-type Prostaglandin D Synthase Gene Expression through De-repression of Notch-HES Signaling and Enhancement of AP-2{beta} Function in Brain-derived TE671 Cells
J. Biol. Chem.,
May 6, 2005;
280(18):
18452 - 18461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Yamashita, Y.-P. Wu, R. Sandhoff, N. Werth, H. Mizukami, J. M. Ellis, J. L. Dupree, R. Geyer, K. Sandhoff, and R. L. Proia
Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions
PNAS,
February 22, 2005;
102(8):
2725 - 2730.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Fujimori, Y. Fujitani, K. Kadoyama, H. Kumanogoh, K. Ishikawa, and Y. Urade
Regulation of Lipocalin-type Prostaglandin D Synthase Gene Expression by Hes-1 through E-box and Interleukin-1beta via Two NF-kappa B Elements in Rat Leptomeningeal Cells
J. Biol. Chem.,
February 14, 2003;
278(8):
6018 - 6026.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|